Does Wegovy make you eat less — and why does it feel different this time?

You open the fridge and realise you are just... not that interested

That is probably the single most common thing people describe in the early weeks of Wegovy. Not nausea putting them off food, not willpower holding them back, simply a quieter inner voice asking for it. Semaglutide binds to GLP-1 receptors in the hypothalamus, the part of the brain that coordinates hunger signals. When those receptors are activated, the brain interprets the body as having eaten enough, even before the plate is empty.

Gastric emptying also slows, meaning the stomach empties its contents into the small intestine more gradually. In practical terms, a smaller portion can feel just as filling as a larger one used to. The two effects compound: less urgency before a meal, more satisfaction during it, and a longer stretch before hunger returns.

None of this is the same as feeling sick and therefore not eating. The reduction in hunger on Wegovy is a distinct physiological state, and most people distinguish it clearly from the nausea that can occur in the first few weeks of treatment, the nausea tends to ease; the appetite change tends to persist.

It is worth knowing that the appetite effect builds as the dose increases. Treatment starts at 0.25 mg and moves upward in roughly monthly steps toward 2.4 mg maintenance. Some people notice a noticeable shift early; others find the effect becomes clearer at higher doses. Either pattern is normal.

Why eating less on Wegovy does not mean eating nothing

A quieter appetite is useful. An absent one is not. One practical habit worth building early: before you sit down to eat, run a quick mental check, have you had protein at this meal? Even a small portion matters. Semaglutide can suppress appetite so effectively that some people undereat to the point of losing muscle alongside fat, which is not the goal.

The dietary choices that work alongside Wegovy are not complicated, but they do matter. Adequate protein, enough fluid, and not skipping meals entirely will support the weight loss rather than undermine it. The NHS notes that medicines for obesity work best alongside a reduced-calorie diet and increased activity, semaglutide is licensed on exactly that basis, not as a standalone fix.

Fibre is worth a mention too. Slower gastric emptying combined with low food intake can contribute to constipation, one of the more common gastrointestinal effects of treatment. Vegetables, wholegrains and water help keep things moving. If constipation becomes bothersome, it is worth raising with your prescriber rather than quietly tolerating it.

For context on costs if you are weighing up treatment, the Wegovy pricing page sets out what private prescriptions typically involve in the UK.

The difference between appetite reduction and the side effects some people worry about

There is a distinction worth being clear about. Eating less because food is simply less compelling is the intended pharmacological effect of semaglutide. Eating less because you feel nauseated, or because the thought of food is aversive, sits closer to a side effect, and one worth mentioning to your prescriber if it is persistent or affecting your quality of life.

The most common side effects of Wegovy are gastrointestinal: nausea, loose stools, indigestion, and sometimes vomiting, particularly after dose increases. According to the NHS medicines page for semaglutide, these effects are typically most pronounced in the first days after a new dose and settle over time for most people. They are not the same as the appetite reduction, even though both can reduce food intake in the short term.

The experience of semaglutide reducing hunger is distinct from feeling unwell. If you find yourself unable to eat because you feel consistently sick rather than simply not hungry, that is worth a conversation with your clinical team. A slower titration pace can make a significant difference.

Some people also notice changes beyond appetite, whether Wegovy affects sweating is one of those questions that comes up more than you might expect, and the answer is more nuanced than a simple yes or no.

What happens to appetite if you stop taking Wegovy

This is an honest question and it deserves a straight answer. For most people, the appetite-suppressing effect of semaglutide is tied to the medicine being active in the body. When treatment stops, GLP-1 receptor activation falls, and appetite typically returns, sometimes quickly, sometimes over weeks. The STEP 1 trial, published in the New England Journal of Medicine, included a withdrawal phase that showed participants regained a substantial portion of lost weight after stopping semaglutide, which supports the understanding that obesity is a chronic condition rather than one a course of medicine permanently resolves.

That does not mean treatment is pointless, far from it. For many people, the period on treatment builds habits, resets portion expectations, and delivers meaningful health improvements. But it does mean that decisions about duration and what comes after are worth thinking through with your prescriber from the start, not as an afterthought when you want to stop.

The full overview of Wegovy in the UK covers the licensed use, eligibility criteria, and how the prescription process works. If you are ready to talk to a prescriber about whether semaglutide is appropriate for your situation, you can check your eligibility through a free consultation, a real clinician reviews every submission the same day.